These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23172071)

  • 21. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 22. [New US guidelines. Myocardial infarct is now treated more aggressively].
    MMW Fortschr Med; 2002 May; 144(20):64. PubMed ID: 12119892
    [No Abstract]   [Full Text] [Related]  

  • 23. Practical implications of ACC/AHA 2007 guidelines for the management of unstable angina/non-ST elevation myocardial infarction.
    Patel PD; Arora RR
    Am J Ther; 2010; 17(1):e24-40. PubMed ID: 19262369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
    Rupprecht HJ
    MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
    [No Abstract]   [Full Text] [Related]  

  • 25. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction.
    Kopp CW; Gremmel T; Steiner S; Seidinger D; Minar E; Maurer G; Huber K
    Platelets; 2011; 22(7):530-6. PubMed ID: 21557685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New trials and therapies for acute myocardial infarction.
    Gumina RJ
    Med Clin North Am; 2007 Jul; 91(4):729-49; xii. PubMed ID: 17640545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet GP IIb/IIIa inhibition in unstable angina and non-ST segment elevation MI: application of the ACC/AHA guidelines.
    Young JJ; Choo JK; Kereiakes DJ; ;
    J Invasive Cardiol; 2003 Feb; 15(2):102-7; quiz 108. PubMed ID: 12556626
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet P2 receptors: old and new targets for antithrombotic drugs.
    Cattaneo M
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to STEMI and NSTEMI.
    Daga LC; Kaul U; Mansoor A
    J Assoc Physicians India; 2011 Dec; 59 Suppl():19-25. PubMed ID: 22624277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice.
    Wessler JD; Stant J; Duru S; Rabbani L; Kirtane AJ
    Am J Cardiol; 2015 Mar; 115(5 Suppl):23A-8A. PubMed ID: 25728971
    [No Abstract]   [Full Text] [Related]  

  • 33. [New strategies in the management of unstable angina/non-Q infarction: clinical results of the PURSUIT study].
    Chierchia SL
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):593-5. PubMed ID: 12497789
    [No Abstract]   [Full Text] [Related]  

  • 34. 2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice.
    Pollack CV; Roe MT; Peterson ED
    Ann Emerg Med; 2003 Mar; 41(3):355-69. PubMed ID: 12605203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
    Saucedo JF
    Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit.
    Cannon CP;
    Crit Pathw Cardiol; 2008 Mar; 7(1):43-81. PubMed ID: 18458666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspectives in the antiplatelet therapy of thrombotic disorders.
    Breddin HK
    Semin Thromb Hemost; 1989 Apr; 15(2):144-9. PubMed ID: 2665085
    [No Abstract]   [Full Text] [Related]  

  • 39. Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial?
    Serebruany VL
    Am Heart J; 2011 Jan; 161(1):1-4. PubMed ID: 21167333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tirofiban in acute coronary syndromes.
    Gomma A; Collinson J; Purcell H; Flather M
    Int J Clin Pract; 2000 Mar; 54(2):121-4. PubMed ID: 10824369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.